Short-term And Longer-term Cognitive Impact Of Neurochecks
Public ClinicalTrials.gov record NCT06219889. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Short-term And Longer-term Cognitive Impact Of Hourly Neurochecks In Acute Brain Injury
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The proposed research plan seeks to understand the impact of sleep disruption in the Neurological Intensive Care Unit (ICU) on older patients with acute brain injury (ABI). In current practice, the neurocritical care community performs frequent serial neurological examinations ("neurochecks") in an effort to monitor patients for neurological deterioration following brain injury. Many neurocritical patients are older and/or cognitively fragile, and delirium is common. Although ICU delirium is multifaceted, frequent neurochecks may represent a modifiable risk factor if the investigators can better understand the risks and benefits of various neurocheck frequencies. This project will randomize patients with acute spontaneous intracerebral hemorrhage (ICH) to either hourly (Q1) or every-other-hour (Q2) neurochecks and evaluate the impact of neurocheck frequency on delirium. Second, longer-term cognitive outcomes will be investigated in patients with ICH randomized to Q1 versus Q2 neurochecks with the goal of identifying whether hourly neurochecks increase the risk for dementia.
Study identification
- NCT ID
- NCT06219889
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2024
- Primary completion
- Oct 30, 2028
- Completion
- Oct 30, 2029
- Last update posted
- Sep 9, 2025
2024 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC San Diego Health | San Diego | California | 92103 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Intracerebral Hemorrhage trials
Other public records listing Intracerebral Hemorrhage. Sorted by last update posted; newest first. Not a recommendation.
- NCT06799390: Auricular VNS Following Intracerebral Hemorrhage Recruiting
- NCT05089331: ROSE-Longitudinal Assessment With Neuroimaging Active, not recruiting
- NCT07651631: Rapid Evacuation and Access of Cerebral Hemorrhage Registry Not yet recruiting
- NCT05491980: Florida Cerebrovascular Disease Biorepository and Genomics Center Active, not recruiting
- NCT03907046: Anticoagulation in ICH Survivors for Stroke Prevention and Recovery Recruiting
- NCT07455201: Evaluating a Prototype CT Scan for ICH Evacuation Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06219889, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2025 · Synced Jul 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06219889 live on ClinicalTrials.gov.